NovoCure Ltd·4

Feb 29, 4:36 PM ET

Puri Michal Nath 4

4 · NovoCure Ltd · Filed Feb 29, 2024

Insider Transaction Report

Form 4
Period: 2024-02-27
Puri Michal Nath
Chief Human Resources Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+109,443$1,783,921109,443 total
    Exercise: $16.30From: 2025-02-27Exp: 2034-02-26Ordinary Shares (109,443 underlying)
  • Award

    Ordinary Shares

    2024-02-27$16.30/sh+71,574$1,166,656109,167 total
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy 109,443 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT